A. Urwyler

1.4k total citations
22 papers, 677 citations indexed

About

A. Urwyler is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Biomedical Engineering. According to data from OpenAlex, A. Urwyler has authored 22 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Biomedical Engineering. Recurrent topics in A. Urwyler's work include Ion channel regulation and function (12 papers), Cardiac electrophysiology and arrhythmias (7 papers) and Ultrasound and Hyperthermia Applications (3 papers). A. Urwyler is often cited by papers focused on Ion channel regulation and function (12 papers), Cardiac electrophysiology and arrhythmias (7 papers) and Ultrasound and Hyperthermia Applications (3 papers). A. Urwyler collaborates with scholars based in Switzerland, Germany and United Kingdom. A. Urwyler's co-authors include Tommie V. McCarthy, Sarah P. West, Thomas Deufel, C. R. Müller, Marc Snoeck, Klaus P.E. Glahn, F.R. ELLIS, Francesco Zorzato, K. Censier and Susan Treves and has published in prestigious journals such as Journal of Clinical Investigation, Anesthesiology and British Journal of Anaesthesia.

In The Last Decade

A. Urwyler

21 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Urwyler Switzerland 11 434 346 93 90 88 22 677
P Adnet France 14 468 1.1× 496 1.4× 96 1.0× 88 1.0× 67 0.8× 56 850
P Stieglitz France 10 392 0.9× 306 0.9× 64 0.7× 94 1.0× 115 1.3× 36 678
E. H. Flewellen United States 12 320 0.7× 189 0.5× 58 0.6× 52 0.6× 48 0.5× 33 506
Wyun Kon Park South Korea 10 158 0.4× 215 0.6× 175 1.9× 85 0.9× 126 1.4× 47 519
Albert Urwyler Switzerland 13 213 0.5× 236 0.7× 266 2.9× 112 1.2× 434 4.9× 23 861
W T Woods United States 15 165 0.4× 320 0.9× 19 0.2× 52 0.6× 79 0.9× 30 697
Nediljka Buljubasíc United States 11 128 0.3× 247 0.7× 46 0.5× 73 0.8× 54 0.6× 21 461
Hirobumi Okawa Japan 16 337 0.8× 145 0.4× 102 1.1× 172 1.9× 252 2.9× 42 823
Henrik Rüffert Germany 9 199 0.5× 139 0.4× 39 0.4× 48 0.5× 38 0.4× 22 337
S M Sapsed-Byrne United Kingdom 13 92 0.2× 138 0.4× 145 1.6× 109 1.2× 130 1.5× 25 474

Countries citing papers authored by A. Urwyler

Since Specialization
Citations

This map shows the geographic impact of A. Urwyler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Urwyler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Urwyler more than expected).

Fields of papers citing papers by A. Urwyler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Urwyler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Urwyler. The network helps show where A. Urwyler may publish in the future.

Co-authorship network of co-authors of A. Urwyler

This figure shows the co-authorship network connecting the top 25 collaborators of A. Urwyler. A scholar is included among the top collaborators of A. Urwyler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Urwyler. A. Urwyler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hopkins, Philip M., Henrik Rüffert, Marc Snoeck, et al.. (2015). European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility. British Journal of Anaesthesia. 115(4). 531–539. 129 indexed citations
2.
Glahn, Klaus P.E., F.R. ELLIS, P.J. Halsall, et al.. (2010). Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. British Journal of Anaesthesia. 105(4). 417–420. 119 indexed citations
3.
Urwyler, A., et al.. (2005). Decreased isometric skeletal muscle force in critically ill patients. Swiss Medical Weekly. 135(3738). 555–555. 15 indexed citations
4.
Stotz, M., et al.. (2004). Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication. British Journal of Anaesthesia. 93(6). 868–871. 17 indexed citations
5.
Girard, Thierry, et al.. (2004). Similar susceptibility to halothane, caffeine and ryanodine in vitro reflects pharmacogenetic variability of malignant hyperthermia. European Journal of Anaesthesiology. 21(2). 151–157. 6 indexed citations
6.
Zorzato, Francesco, et al.. (2004). Effect of three anaesthetic techniques on isometric skeletal muscle strength. British Journal of Anaesthesia. 92(3). 367–372. 34 indexed citations
7.
Girard, Thierry, Susan Treves, K. Censier, et al.. (2002). Phenotyping malignant hyperthermia susceptibility by measuring halothane-induced changes in myoplasmic calcium concentration in cultured human skeletal muscle cells. British Journal of Anaesthesia. 89(4). 571–579. 25 indexed citations
8.
Urwyler, A., Thomas Deufel, Tommie V. McCarthy, & Sarah P. West. (2001). Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. British Journal of Anaesthesia. 86(2). 283–287. 160 indexed citations
9.
Censier, K., A. Urwyler, Francesco Zorzato, & Susan Treves. (1998). Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.. Journal of Clinical Investigation. 101(6). 1233–1242. 74 indexed citations
10.
Seeberger, Manfred D. & A. Urwyler. (1995). Paravascular lumbar plexus block: block extension after femoral nerve stimulation and injection of 20 vs. 40 ml mepivacaine 10 mg/ml. Acta Anaesthesiologica Scandinavica. 39(6). 769–773. 42 indexed citations
11.
Urwyler, A. & E. Härtung. (1994). Die Maligne Hyperthermie. Der Anaesthesist. 43(8). 557–569. 9 indexed citations
12.
Schumacher, Peter, et al.. (1994). Control of Heart Rate and Blood Pressure Response to Intubation by Lidocaine and/or Esmolol. Anesthesiology. 81(SUPPLEMENT). A99–A99. 3 indexed citations
13.
14.
Reber, A., Philippe Schumacher, & A. Urwyler. (1993). Effects of three different types of management on the elimination kinetics of volatile anaesthetics. Anaesthesia. 48(10). 862–865. 11 indexed citations
15.
Frei, Franz J. & A. Urwyler. (1992). [Neonatal resuscitation in the delivery room. What role does the anesthetist play?].. PubMed. 41(7). 403–7. 1 indexed citations
16.
Schumacher, Philippe, Gisela C. Stotz, Matthias Schneider, & A. Urwyler. (1992). Laryngospasm during transtracheal high frequency jet ventilation. Anaesthesia. 47(10). 855–856. 14 indexed citations
17.
Urwyler, A., B Funk, K. Censier, & Jürgen Drewe. (1992). Effect of halothane equilibration kinetics on in vitro muscle contractures for malignant hyperthermia screening. Acta Anaesthesiologica Scandinavica. 36(2). 115–118. 3 indexed citations
18.
Ummenhofer, W., Franz J. Frei, A. Urwyler, & Jürgen Drewe. (1992). Emergency laboratory studies in pediatric patients: Does bone marrow aspirate give accurate results?. Resuscitation. 24(2). 185–185. 3 indexed citations
19.
Urwyler, A., et al.. (1991). [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].. PubMed. 121(16). 566–71. 2 indexed citations
20.
Urwyler, A., F.R. ELLIS, P.J. Halsall, & Philip M. Hopkins. (1990). MUSCLE RELAXATION RATES IN INDIVIDUALS SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA. British Journal of Anaesthesia. 65(3). 421–423. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Adnet Breakdown of academic impact, for papers by P Stieglitz Breakdown of academic impact, for papers by E. H. Flewellen Breakdown of academic impact, for papers by Wyun Kon Park Breakdown of academic impact, for papers by Albert Urwyler Breakdown of academic impact, for papers by W T Woods Breakdown of academic impact, for papers by Nediljka Buljubasíc Breakdown of academic impact, for papers by Hirobumi Okawa Breakdown of academic impact, for papers by Henrik Rüffert Breakdown of academic impact, for papers by S M Sapsed-Byrne
Rankless by CCL
2026